Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous Thromboembolism
- 1 February 1989
- Vol. 95 (2) , 88S-97S
- https://doi.org/10.1378/chest.95.2_supplement.88s
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: Overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trialsEuropean Heart Journal, 1985
- Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1979
- AUSTRALIAN MULTICENTRE TRIAL OF STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTIONThe Medical Journal of Australia, 1977
- Streptokinase in acute myocardial infarction: a controlled multicentre study in the United Kingdom.BMJ, 1976
- A pilot study of streptokinase therapy in acute myocardial infarction: observations on complications and relation to trial designAmerican Heart Journal, 1974
- Die Kurzzeitfibrinolyse beim akuten MyokardinfarktDeutsche Medizinische Wochenschrift (1946), 1973
- CONTROLLED TRIAL OF STREPTOKINASE AND HEPARIN IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1971
- Streptokinase in Recent Myocardial Infarction: A Controlled Multicentre TrialBMJ, 1971
- FIBRINOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTIONActa Medica Scandinavica, 1971
- Controlled study of the treatment of coronary occlusion with urokinase-activated human plasminThe American Journal of Cardiology, 1965